Stay updated on TGRX-326 Chinese Phase I Clinical Trial

Sign up to get notified when there's something new on the TGRX-326 Chinese Phase I Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TGRX-326 Chinese Phase I Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.4, has been added to the Study Record Versions, replacing the previous v3.5.3 in the history. This indicates an updated revision entry on the page reflecting a newer version of the study record.
    Difference
    0.1%
    Check dated 2026-05-15T14:23:24.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    This updates the displayed application/version revision for the ClinicalTrials.gov page from v3.5.2 to v3.5.3 without altering the study record’s content. The record history list of submissions remains the same.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:41.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:44:24.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Sponsor entity updated from Shenzhen TargetRx, Inc. to Shenzhen TargetRx Co., Ltd.
    Difference
    0.2%
    Check dated 2026-03-26T11:47:12.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Contacts/Locations and Sponsor/Collaborators sections were added; the record history shows revision to v3.5.0 (replacing v3.4.3).
    Difference
    0.3%
    Check dated 2026-03-19T06:11:19.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; removed Revision: v3.4.2 from the Record History.
    Difference
    0.1%
    Check dated 2026-03-12T02:15:33.000Z thumbnail image

Stay in the know with updates to TGRX-326 Chinese Phase I Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TGRX-326 Chinese Phase I Clinical Trial page.